These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 1832610

  • 1. [Hypercholesterolemia: therapeutic approach].
    Alessandri C, Peverini F.
    Clin Ter; 1991 Jun 30; 137(6):373-97. PubMed ID: 1832610
    [Abstract] [Full Text] [Related]

  • 2. HMG CoA reductase inhibitors as lipid-lowering agents: five years experience with lovastatin and an appraisal of simvastatin and pravastatin.
    Maher VM, Thompson GR.
    Q J Med; 1990 Feb 30; 74(274):165-75. PubMed ID: 2111917
    [Abstract] [Full Text] [Related]

  • 3. [Clinical evaluation of a selective inhibitor of cholesterol synthesis: pravastatin].
    Alessandri C, Peverini F.
    Minerva Med; 1992 Nov 30; 83(11):677-93. PubMed ID: 1461539
    [Abstract] [Full Text] [Related]

  • 4. [Effectiveness and tolerability of simvastatin in patients with moderate-to-severe hypercholesterolemia. Results of a 12-month study].
    Ghizzoni G, Rusconi C, Faggiano P, Sabatini T, Oneglia C, Gardini A.
    Minerva Cardioangiol; 1993 Mar 30; 41(3):105-9. PubMed ID: 8510811
    [Abstract] [Full Text] [Related]

  • 5. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR, Gandhi S, Blasetto J, Heien H, Sasane R, Nelson SP.
    Am J Geriatr Pharmacother; 2007 Sep 30; 5(3):185-94. PubMed ID: 17996658
    [Abstract] [Full Text] [Related]

  • 6. Treatment of heterozygous familial hypercholesterolemia with lipid-lowering drugs.
    Illingworth DR, Bacon S.
    Arteriosclerosis; 1989 Sep 30; 9(1 Suppl):I121-34. PubMed ID: 2492189
    [Abstract] [Full Text] [Related]

  • 7. [Effects and side effects of a 1-year treatment of primary hypercholesterolemia with simvastatin].
    Brocard JJ, Keller U, Oberhänsli A, Riesen WF.
    Schweiz Med Wochenschr; 1991 Jun 29; 121(26):977-83. PubMed ID: 1862314
    [Abstract] [Full Text] [Related]

  • 8. [Simvastatin versus gemfibrozil in the treatment of primary hypercholesterolemia in hypertensive patients treated with hydrochlorothiazide].
    Berioli S, Bentivoglio M, Conti R, Osanna RA, Savino K, Zollino L, Corea L.
    Cardiologia; 1990 Apr 29; 35(4):335-40. PubMed ID: 2245435
    [Abstract] [Full Text] [Related]

  • 9. A review of clinical trials comparing HMG-CoA reductase inhibitors.
    Illingworth DR, Tobert JA.
    Clin Ther; 1994 Apr 29; 16(3):366-85; discussion 365. PubMed ID: 7923304
    [Abstract] [Full Text] [Related]

  • 10. HMG CoA reductase inhibitors in the treatment of hypercholesterolaemias.
    Aronson JK, Ng LL.
    Q J Med; 1990 Feb 29; 74(274):111-5. PubMed ID: 2111916
    [No Abstract] [Full Text] [Related]

  • 11. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.
    Lennernäs H, Fager G.
    Clin Pharmacokinet; 1997 May 29; 32(5):403-25. PubMed ID: 9160173
    [Abstract] [Full Text] [Related]

  • 12. Recent developments in coronary heart disease prevention: the Scandinavian and west of Scotland studies.
    Elam MB, Cushman W, Applegate WB, Heimberg M.
    Tenn Med; 1997 May 29; 90(5):189-92. PubMed ID: 9130876
    [No Abstract] [Full Text] [Related]

  • 13. [Therapy of hypercholesterolemia after heart transplantation with the HMG-CoA reductase inhibitor simvastatin in long-term follow-up].
    Wenke K, Thiery J, Meiser B, Arndtz N, Seidel D, Reichart B.
    Z Kardiol; 1995 Feb 29; 84(2):130-6. PubMed ID: 7717016
    [Abstract] [Full Text] [Related]

  • 14. [Comparison of 2 cholesterol synthesis inhibitors (simvastatin and pravastatin)].
    Golay A, Lehmann T, James R, Pometta D.
    Schweiz Med Wochenschr; 1993 Aug 21; 123(33):1553-8. PubMed ID: 8372340
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Extended worldwide experience. HMG-CoA reductase inhibitors: lovastatin and simvastatin].
    Mantell G.
    Therapie; 1992 Aug 21; 47(2):161-4. PubMed ID: 1412144
    [Abstract] [Full Text] [Related]

  • 17. [Maximal therapy of hypercholesterolemia in coronary heart disease].
    Thiery J, Armstrong V, Bosch T, Eisenhauer T, Schuff-Werner P, Seidel D.
    Ther Umsch; 1990 Jun 21; 47(6):520-9. PubMed ID: 2375008
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Therapy of hypercholesterolemia and hypertriglyceridemia. Comparison of the lipid-lowering effect of simvastatin and tiadenol].
    Serra T, Gavelli MS, Vitaliano E, Santini G, Catalano A, Rossi FG, Tozzi J, Caridis R, Guarini G.
    Clin Ter; 1990 Mar 15; 132(5):307-13. PubMed ID: 2139833
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.